Company Profile
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Latest News
Fed Meeting, Inflation, Boeing, Meta, Apple, Exxon, and More to Watch This Week
4 Big Tech earnings reports, a Fed meeting, and $100 oil: It's the busiest week of the quarter
Earnings Calendar and Analysis for This Week (July 27-31)
Intuitive Surgical Stock Is On Sale, But Is The Growth Story Changing?
The Zacks Analyst Blog Highlights Qualcomm, Intuitive Surgical, Stryker, Frequency Electronics and Good Times Restaurants
| Sector | Healthcare |
| Industry | Medical Devices |
| Website | https://www.stryker.com |
| Audit Risk | 10 |
| Board Risk | 9 |
| Overall Risk | 8 |
| Market Cap | 126.60B |
| Trailing P/E | 38.18 |
| Forward P/E | 19.75 |
| Dividend Rate | 3.52 |
| Dividend Yield | 1.07% |
| Trailing Annual Div. Rate | 3.44 |
| Trailing Annual Div. Yield | 1.08% |
| Trailing EPS | 8.65 |
| Forward EPS | 16.72 |
| Book Value | 59.94 |
| Price-to-Book | 5.51 |
| Enterprise-to-Revenue | 5.5 |
| Enterprise-to-EBITDA | 20.07 |
| Short Ratio | 2.55 |
| Ex-Dividend Date | 06/30/2026 |
| Dividend Date | 07/31/2026 |
| Earnings Date | 07/30/2026 |
| Earnings Call Date | 07/30/2026 |
| Earnings Average | 3.49 |
| Earnings Low | 3.36 |
| Earnings High | 3.61 |
| Revenue Average | 6.58B |
| Revenue Low | 6.52B |
| Revenue High | 6.80B |